Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
Sponsor: Novartis Pharmaceuticals
Summary
SEPROS is a non-interventional study, based on primary data collection of MS adult patients who initiated ofatumumab as per neurologist practice and regardless of the study protocol.
Official title: This is a Non-interventional, Prospective, Multicenter Study Conducted in France. The Primary Objective of This Study is to Describe the Quality of Life of MS Patients After Initiation of Treatment With Ofatumumab.
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
302
Start Date
2023-12-21
Completion Date
2026-07-31
Last Updated
2026-02-06
Healthy Volunteers
No
Conditions
Interventions
ofatumumab
There is no treatment allocation. Participants with MS that initiated treatment with ofatumumabas per neurologist practice and regardless of the study protocol
Locations (49)
Novartis Investigative Site
Angers, France, France
Novartis Investigative Site
Paris, France, France
Novartis Investigative Site
Agen, France
Novartis Investigative Site
Altkirch, France
Novartis Investigative Site
Amiens, France
Novartis Investigative Site
Belfort, France
Novartis Investigative Site
Bordeaux, France
Novartis Investigative Site
Boulogne-sur-Mer, France
Novartis Investigative Site
Brest, France
Novartis Investigative Site
Brunstatt Didenheim, France
Novartis Investigative Site
Cahors, France
Novartis Investigative Site
Chambéry, France
Novartis Investigative Site
Cherbourg Octeville, France
Novartis Investigative Site
Compiègne, France
Novartis Investigative Site
Contamine-sur-Arve, France
Novartis Investigative Site
Dax, France
Novartis Investigative Site
Gonesse, France
Novartis Investigative Site
Le Bouscat, France
Novartis Investigative Site
Le Coudray, France
Novartis Investigative Site
Lens, France
Novartis Investigative Site
Libourne, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Lyon, France
Novartis Investigative Site
Lyon, France
Novartis Investigative Site
Mantes-la-Jolie, France
Novartis Investigative Site
Marseille 01, France
Novartis Investigative Site
Meaux, France
Novartis Investigative Site
Metz-Tessy, France
Novartis Investigative Site
Mont-de-Marsan, France
Novartis Investigative Site
Montluçon, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Mulhouse, France
Novartis Investigative Site
Nîmes, France
Novartis Investigative Site
Orsay, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Poissy, France
Novartis Investigative Site
Quint-Fonsegrives, France
Novartis Investigative Site
Reims, France
Novartis Investigative Site
Rennes, France
Novartis Investigative Site
Saverne, France
Novartis Investigative Site
Sélestat, France
Novartis Investigative Site
Strasbourg, France
Novartis Investigative Site
Toulouse, France
Novartis Investigative Site
Tours, France
Novartis Investigative Site
Valence, France
Novartis Investigative Site
Vannes, France
Novartis Investigative Site
Villeurbanne, France